Skip to content

Chemed CHE Deferred Tax Assets, Operating Loss Carryforwards

Deferred Tax Assets, Operating Loss Carryforwards at other companies

L3Harris Technologies logo
L3Harris TechnologiesLHX
$37M-54.3%
Popular logo
PopularBPOP
$627.73M-5.2%
General Dynamics logo
General DynamicsGD
$663M+5.2%
Rockwell Automation logo
Rockwell AutomationROK
$62M-11.4%
Mondelez International logo
Mondelez InternationalMDLZ
$752M+10.4%
ESAB logo
ESABESAB
$2.2M-56.9%

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwards.

The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's deferred tax assets, operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's deferred tax assets, operating loss carryforwards?
Chemed (CHE) reported deferred tax assets, operating loss carryforwards of $2.38M in Q4 2025.
How has Chemed's deferred tax assets, operating loss carryforwards changed year-over-year?
Chemed's deferred tax assets, operating loss carryforwards increased by 29.6% year-over-year, from $1.84M to $2.38M.
What is the long-term trend for Chemed's deferred tax assets, operating loss carryforwards?
Over 5 years (2020 to 2025), Chemed's deferred tax assets, operating loss carryforwards has grown at a 3.3% compound annual growth rate (CAGR), from $2.03M to $2.38M.